Floatz logo

Gadobutrol

Metastatic Malignant Neoplasm in the Liver

M.D. Anderson Cancer CenterSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
81/ 100

Competitive context

20 Active assets in the Metastatic Malignant Neoplasm in the Liver cohort.

Asset / SponsorPhaseRating
Eloxatin
ECOG-ACRIN Cancer Research Group
Phase 3BB
Oxodotreotide
Vanderbilt-Ingram Cancer Center
Phase 4B
FLUOROURACILUM
ECOG-ACRIN Cancer Research Group
Phase 3B
Calcium folinate pentahydrate
ECOG-ACRIN Cancer Research Group
Phase 3B
Irinotecan
ECOG-ACRIN Cancer Research Group
Phase 3B

View all 29 →

Same molecule, other indications

Gadobutrol is also rated in:

cognitive disorderDormant
BB
Indicative ·
65 / 100
View asset →
Contrast MediaDormant
BB
Indicative ·
65 / 100
View asset →
Magnetic Resonance ImagingDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →